These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36118915)

  • 61. The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma.
    Ma T; Wiggins CC; Kornatowski BM; Hailat RS; Clayburn AJ; Guo WL; Johnson PW; Senefeld JW; Klassen SA; Baker SE; Bruno KA; Fairweather D; Wright RS; Carter RE; Li C; Joyner MJ; Paneth NS
    Front Med (Lausanne); 2021; 8():707895. PubMed ID: 35155458
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India.
    Elkhalifa AME; Nabi SU; Shah NN; Dar KA; Quibtiya S; Bashir SM; Ali SI; Taifa S; Hussain I
    Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical Characteristics and Outcomes of Vaccinated VS Non-Vaccinated Critically Ill COVID-19 Patients: Retrospective Observation Study.
    AlQahtani SY; Alabdulqader AA; Al Mashhour WA; Aldawood ZM; Al Masari OA; Alotaibi T; AlGhamdi ZM; Alzahrani IM; Albaloushi NN
    Infect Drug Resist; 2023; 16():3329-3338. PubMed ID: 37274364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma.
    Ma T; Wiggins CC; Kornatowski BM; Hailat RS; Clayburn AC; Guo W; Johnson PW; Senefeld JW; Klassen SA; Baker SE; Bruno KA; Fairweather D; Wright RS; Carter RE; Li C; Joyner MJ; Paneth N
    medRxiv; 2021 Jan; ():. PubMed ID: 33501470
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of Convalescent Plasma Therapy on Clinical Improvement of COVID-19 Patients: A Randomized Clinical Trial.
    Jalili E; Khazaei S; Mohammadi A; Keramat F; Hashemi SH; Bashirian S; Kiani T; Azizi Jalilian F; Ghelichkhani S; Karami M; Farrokhi M; Heidarimoghadam R; Abbasi Garavand T; Daneshyar E; Abbasi M
    Tanaffos; 2022 Jan; 21(1):24-30. PubMed ID: 36258918
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study.
    Alwafi H; Naser AY; Qanash S; Brinji AS; Ghazawi MA; Alotaibi B; Alghamdi A; Alrhmani A; Fatehaldin R; Alelyani A; Basfar A; AlBarakati A; Alsharif GF; Obaid EF; Shabrawishi M
    J Multidiscip Healthc; 2021; 14():839-852. PubMed ID: 33883900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China.
    Hu X; Hu C; Jiang D; Zuo Q; Li Y; Wang Y; Chen X
    Dose Response; 2020; 18(4):1559325820979921. PubMed ID: 33402882
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paediatric critical COVID-19 and mortality in a multinational prospective cohort.
    Gonzalez-Dambrauskas S; Vasquez-Hoyos P; Camporesi A; Cantillano EM; Dallefeld S; Dominguez-Rojas J; Francoeur C; Gurbanov A; Mazzillo-Vega L; Shein SL; Yock-Corrales A; Karsies T;
    Lancet Reg Health Am; 2022 Aug; 12():100272. PubMed ID: 35599855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.
    Schwartz SP; Thompson P; Smith M; Lercher DM; Rimland CA; Bartelt L; Park YA; Weiss S; Markmann AJ; Raut R; Premkumar L; Kuruc J; Willis Z
    Crit Care Explor; 2020 Oct; 2(10):e0237. PubMed ID: 33063037
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity.
    Wang Y; Xu Z; Xu X; Yang S; Li Y; Zhang H; Zhang Y; Wang FS; Wang Y; Bi J
    Front Pharmacol; 2024; 15():1421516. PubMed ID: 39148549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors Associated with 30-Day in-Hospital Mortality Among Patients Admitted with Severe Covid-19 in Mbarara Regional Referral Hospital.
    Mutekanga A; Nuwagira E; Kumbakumba E; Nyaiteera V; Asiimwe S; Gasumuni M; Wandera N; Natumanya R; Akena D; Senoga S; Kyobe Kiwanuka J; Kateregga G; Munyarugero E; Abeya FC; Obwoya PS; Ttendo S; Muhindo R
    Infect Drug Resist; 2022; 15():7157-7164. PubMed ID: 36510588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of Poor Outcome among Critically Ill COVID-19 Patients: A Nationally Representative Sample of the Saudi Arabian Population.
    Almutairi MS; Assiri AM; Almohammed OA
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between Plasma Levels of Zinc and Magnesium with the Treatment Process and Mortality Risk in COVID-19 Patients.
    Radpay R; Eghtesadi S
    Tanaffos; 2023 Feb; 22(2):236-247. PubMed ID: 38628887
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors of Mortality Among Post-COVID-19 Discharged Patients in Northern India: A Case-Control Study.
    Kumar A; Jatteppanvar B; Panda PK; Dhangar P; Bahurupi YA
    Cureus; 2023 Mar; 15(3):e36883. PubMed ID: 37128527
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran.
    Iranijam E; Ghobadi H; Matin S; Habibzadeh S; Zandian H; Mohammadshahi J; Fooladi S; Dargahi A; Safarzadeh E; Negaresh M; Hosseini J; Samadi AH; Hoseininia S; Salehzadeh H; Dezhkam S
    J Educ Health Promot; 2022; 11():266. PubMed ID: 36325204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Infusion of Convalescent Plasma is associated with Clinical Improvement in Critically Ill Patients With Covid-19: A Comment.
    Ruiz-Argüelles GJ
    Rev Invest Clin; 2020 May; 72(5):. PubMed ID: 33120400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.
    Das SK; Ranabhat K; Bhattarai S; Karki KB; Gyanwali P; Paneru HR; Nepal B; Dumre SP; Acharya SP
    Clin Case Rep; 2021 Apr; 9(4):2132-2137. PubMed ID: 33821192
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID-19.
    Donzelli M; Ippolito M; Catalisano G; Renda B; Tarantino F; Diquattro O; Cortegiani A
    Clin Case Rep; 2020 Dec; 8(12):3352-3358. PubMed ID: 33363933
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Results of the use of plasma from convalescent patients of COVID 19 in critically ill patients].
    Astola Hidalgo I; Fernández Rodríguez A; Martínez Revuelta E; Martínez Revuelta M; Ojea AM; Herrero Puente P; Escudero Augusto D
    Med Intensiva; 2023 Apr; 47(4):232-234. PubMed ID: 36090006
    [No Abstract]   [Full Text] [Related]  

  • 80. The emergency use authorization for COVID-19 convalescent plasma reduced mortality.
    Paneth N; Casadevall A; Joyner M
    Health Sci Rep; 2023 Aug; 6(8):e1463. PubMed ID: 37554952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.